Tonix in the News

Benzinga | Jul 25, 2022

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

New Bedford Guide | Jun 22, 2022

Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park

BioCentury | Jun 14, 2022

Poxvirus agents, by the mechanisms

The New York Times | Jun 3, 2022

21 Americans Infected With Monkeypox, C.D.C. Reports

Bioprocess Online | May 31, 2022

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. (Podcast)

Proactive | May 25, 2022

Tonix Pharmaceuticals Talks Through its 1Q 2022 Financial and Operational Highlights

Benzinga | May 5, 2022

At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines

Bloomberg | May 2, 2022

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

Benzinga | Apr 7, 2022

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

FiercePharma | Mar 8, 2022

Mass General plans study of nasally delivered binge eating disorder drug

Clinical Trials Arena | Feb 8, 2022

Long Covid-19: Tonix reveals Phase II trial design plans

Benzinga | Feb 1, 2022

Could This Be A Potential New Weapon In The Fight Against COVID-19?

HCP Live | Nov 6, 2021

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Maryland.gov | Oct 20, 2021

Tonix Pharmaceuticals expands into Frederick, Md.

The Frederick News-Post | Oct 18, 2021

New Infectious Disease Research and Development Center Opens in Frederick

WDVM News | Oct 18, 2021

Tonix Pharmaceuticals comes to Frederick

Bloomberg | Aug 23, 2021

FDA Grants Full Approval of Pfizer-BioNTech Vaccine (Podcast)

Boston Business Journal | Aug 9, 2021

Biopharma company Tonix expanding to New Bedford

Boston Globe | Aug 2, 2021

Talking Points: N.J. biotech plans to manufacture vaccines in new Mass. plant

Baltimore Business Journal | Jul 27, 2021

Tonix is enrolling participants in a Phase 3 trial for fibromyalgia, the RESILIENT study. For more information, please visit www.resilientstudy.com or www.clinicaltrials.gov (NCT05273749).

Tonix in the News

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park

Poxvirus agents, by the mechanisms

21 Americans Infected With Monkeypox, C.D.C. Reports

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. (Podcast)

Tonix Pharmaceuticals Talks Through its 1Q 2022 Financial and Operational Highlights

At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

Mass General plans study of nasally delivered binge eating disorder drug

Long Covid-19: Tonix reveals Phase II trial design plans

Could This Be A Potential New Weapon In The Fight Against COVID-19?

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Tonix Pharmaceuticals expands into Frederick, Md.

New Infectious Disease Research and Development Center Opens in Frederick

Tonix Pharmaceuticals comes to Frederick

FDA Grants Full Approval of Pfizer-BioNTech Vaccine (Podcast)

Biopharma company Tonix expanding to New Bedford

Talking Points: N.J. biotech plans to manufacture vaccines in new Mass. plant

New Jersey pharma company to purchase Frederick R&D facility